Literature DB >> 3086164

Acetone metabolism in humans during diabetic ketoacidosis.

G A Reichard, C L Skutches, R D Hoeldtke, O E Owen.   

Abstract

Plasma acetone turnover rates were measured with the primed continuous infusion of 2-[14C]acetone in patients with moderate to severe diabetic ketoacidosis. Plasma acetone turnover rates ranged from 1.52 to 15.9 mumol X kg-1 X min-1 (108-1038 mumol X 1.73 m-2 X min-1) and were directly related to the plasma acetone concentrations that ranged from 0.47 to 7.61 mM. The average acetone turnover rate was 6.45 mumol X kg-1 X min-1 (533 mumol X 1.73 m-2 X min-1), a value twice that obtained in a similar group of diabetic ketoacidotic patients via the single-injection technique of 2-[14C]acetone administration. Degradation of urine glucose revealed that 14C from administered 2-[14C )acetone was principally located in carbons 1, 2, 5, and 6 of the glucose molecule in five of six patients. This distribution is similar to that expected from 2-[14C]pyruvate, suggesting that acetone was converted to glucose through pyruvate. In one patient, label was located predominantly in glucose carbons 3 and 4, indicating that acetone metabolism may be different in some patients. Acetol (1-hydroxyacetone) and 1,2-propanediol (PPD), two possible metabolites of acetone, were detected in plasma of the patients. The concentrations of Acetol ranged from 0 to 0.48 mM and of PPD ranged from 0 to 0.53 mM. The concentrations of each metabolite were directly related to the plasma acetone concentrations. During the continuous infusion of 2-[14C]acetone, the specific activities of plasma glucose and PPD rose continuously but did not reach constant values. Estimates of the minimal percent plasma glucose and PPD derived from plasma acetone averaged 2.1 and 74%, respectively.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086164     DOI: 10.2337/diab.35.6.668

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  28 in total

1.  Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity--implications for autism.

Authors:  Madhabi Barua; Edmund C Jenkins; Wenqiang Chen; Salomon Kuizon; Raju K Pullarkat; Mohammed A Junaid
Journal:  Autism Res       Date:  2011-04-12       Impact factor: 5.216

Review 2.  The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life.

Authors:  P J Thornalley
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

3.  Optimized heterologous expression of the human zinc enzyme glyoxalase I.

Authors:  M Ridderström; B Mannervik
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

4.  N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins.

Authors:  M U Ahmed; E Brinkmann Frye; T P Degenhardt; S R Thorpe; J W Baynes
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

5.  Glucose formation from methylglyoxal in hepatocytes from streptozotocin-induced diabetic mice: the effect of insulin.

Authors:  M P Kalapos; P Riba; T Garzo; J Mandl
Journal:  Experientia       Date:  1996-08-15

Review 6.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

Review 7.  Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia.

Authors:  Guillermo Umpierrez; Mary Korytkowski
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

8.  Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor.

Authors:  Mohammed A Junaid; Dagmar Kowal; Madhabi Barua; Premila S Pullarkat; Susan Sklower Brooks; Raju K Pullarkat
Journal:  Am J Med Genet A       Date:  2004-11-15       Impact factor: 2.802

9.  Methylglyoxal, glyoxalases and the development of diabetic complications.

Authors:  P J Thornalley
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

Review 10.  Genetics of diabetes complications.

Authors:  Sami Alkayyali; Valeriya Lyssenko
Journal:  Mamm Genome       Date:  2014-08-29       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.